Article
[K-RAS gene mutations in patients with non-small cell lung cancer].
Zhongguo fei ai za zhi = Chinese journal of lung cancer - 1 Jun 2010
Zhang Yang, Pan Zhenkui, Zhang Xing, Xu Fei, Zhang Li
Abstract excerpt
BACKGROUND AND OBJECTIVE: Recent studies indicated that Non-small cell lung cancer (NSCLC) patients with mutant K-RAS failed to benefit from adjuvant chemotherapy, and the cancer did not respond to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). These findings indicated that K-RAS gene status can be a biomarker to predict the sensitivity of EGFR TKIs. The aim of this study is to analyze...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
